About 600 reports

  • B) US cardiovascular disease market size
  • A) Global cardiovascular disease market split

Global Cardiovascular Disease Drugs Market to 2023 - Expiries, Acquisitions and New Products for Deep Vein Thrombosis, Pulmonary Arterial Hypertension and Dyslipidemia to Shake-Up the Competitive Landscape Summary Cardiovascular disease (CVD) is a general term for a variety of different diseases...

  • Cardiovascular Disease
  • World
  • AstraZeneca PLC
  • Merck & Co., Inc.
  • Pfizer Inc.
  • 5.3.1 Cardiovascular Disease
  • Cardiovascular Disease Therapeutics Market, Global,

Frontier Pharma: Cardiovascular Disease - Diverse First-in-Class Molecular Targets to Bridge Unmet Needs in Pulmonary Hypertension, Heart Failure and Atherosclerosis Summary Cardiovascular disease (CVD) is a broad therapy area containing a range of indications relating to the human vasculature, heart and lipid levels....

  • Cardiovascular Disease
  • World
  • Amgen Inc.
  • Bristol-Myers Squibb Company
  • Merck & Co., Inc.
  • A) Global cardiovascular disease market split
  • B) US cardiovascular disease market split

Global Cardiovascular Disease Market to 2022 - Sanofi and Novartis to Become Market Leaders as Praluent and Entresto Drive Revenue Growth Summary Cardiovascular disease (CVD) covers a range of difference diseases and conditions affecting the heart and/or blood vessels. The most crucial risk factors for CVD are hypertension...

  • Cardiovascular Disease
  • World
  • Market Size
  • Novartis AG
  • Sanofi S.A.

The 2020-2025 World Outlook for Cardiovascular Disease (CVD) Treatments ## INTRODUCTION ##. ## OVERVIEW ##. ## WHAT IS LATENT DEMAND AND THE P. I. E.?

  • Cardiovascular Disease
  • Chronic Disease
  • Pathology
  • World
  • Demand

The 2020-2025 World Outlook for Cardiovascular Disease (CVD) Diagnostics ## INTRODUCTION ##. ## OVERVIEW ##. ## WHAT IS LATENT DEMAND AND THE P. I. E.?

  • Cardiovascular Disease
  • Chronic Disease
  • Pathology
  • World
  • Demand
  • CARDIOVASCULAR DISEASE: CLINICAL TRIALS
  • BY APPLICATION [CARDIOVASCULAR DISEASE, NEUROLOGICAL

Ethical concerns regarding embryonic stem cells is expected to drive the overall growth of the synthetic stem cells market. The synthetic stem cells market is expected to grow from USD 14 million in 2023 to USD 37 million by 20283, at a CAGR of 22.5% during the forecast period. The synthetic stem cells market is driven by various factors...

  • Cardiovascular Disease
  • Cell Therapy
  • Stem Cell
  • United States
  • Market Size
  • INCREASING PREVALENCE OF CARDIOVASCULAR DISEASES (CVDS)

About Holter Monitors A Holter monitor is a battery-operated device that measures and records the heart’s activity constantly for 48-72 hours. The device contains electrodes that are attached to the skin. With the help of these electrodes, the ECG is measured constantly. The Holter monitor is used to monitor patients with slow,...

  • Cardiac Monitoring
  • Cardiovascular Disease
  • Medical Device
  • GE Healthcare Limited
  • Mortara Instrument, Inc.
  • INCREASING PREVALENCE OF CARDIOVASCULAR DISEASES (CVDS)
  • MARKET OUTLINE

About Diagnostic Catheters Diagnostic catheter is a thin flexible tube that is inserted into the target site, be it veins, arteries, or uterine cavity for the diagnostic purpose. It also allows injection of radio-opaque dye to the target site for the interventional diagnostic purpose. Diagnostic catheters are used for different...

  • Cardiovascular Disease
  • Abbott
  • Boston Scientific Corporation
  • Cordis Corporation
  • Jude Medical, Inc.
  • Global Cardiovascular Drugs Market, Historic and Forecast, Split By Segment, 2013 - 2021
  • PERSONALIZED MEDICINE FOR TREATMENT OF CARDIOVASCULAR DISORDERS

The innovation of gene testing technologies for the development of personalized medicine for cardiovascular diseases is one of the major trends in the market.

  • Cardiovascular Disease
  • World
  • Merck & Co., Inc.
  • Pfizer Inc.
  • Sanofi S.A.
  • DISTRIBUTION OF CARDIOVASCULAR DISEASE DEATHS, 2015 (IN %)
  • According to European Cardiovascular Diseases Statistics 2017, each year cardiovascular disease (CVD) causes 3.9 million

Executive Summary A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of Global Transdermal Drug Delivery Market. The report analyzes the Global Transdermal Drug Delivery Market...

  • Cardiovascular Disease
  • North America
  • World
  • Boehringer Ingelheim GmbH
  • GlaxoSmithKline plc
  • Cardiovascular Disease Prevelance, By Type ,2016
  • Global Prevalence of Cardiovascular Disease (2012-2016 , Million)

Executive Summary A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of Global Sterile Injectables Market by Molecule Type (Biologic, Small Molecule), Drug Type (Monoclonal Antibody,...

  • Cardiovascular Disease
  • World
  • Market Size
  • Baxter International Inc.
  • Gilead Sciences, Inc.
  • INCREASING PREVALENCE OF CARDIOVASCULAR DISEASES (CVDS)

About Cardiac Monitoring Cardiac monitoring refers to the continuous or intermittent observation of heart activity to determine the health of the heart. It helps diagnose cardiac arrhythmias and other heart conditions. Cardiac monitoring devices include ECG devices, cardiac event monitors, ILRs, and COM devices. ECG devices...

  • Cardiovascular Disease
  • World
  • Forecast
  • GE Healthcare Limited
  • Medtronic, Inc.
  • INCREASING AWARENESS ABOUT CARDIOVASCULAR DISEASES (CVDS)
  • INCREASING PREVALENCE OF CARDIOVASCULAR AND NEUROLOGICAL DISORDERS

About Medical Electrodes Medical electrodes are an integral part of certain diagnostic and therapeutic medical devices. They provide an ideal electric contract between the patient and the device that is used to measure or record activity. They aid in surface quantification of the internal ionic current in non-invasive...

  • Cardiovascular Disease
  • Medical Equipment
  • World
  • Forecast
  • Medtronic, Inc.
  • CARDIOVASCULAR DISEASE SEGMENT TO ACCOUNT FOR THE LARGEST
  • CARDIOVASCULAR DISEASE APPLICATIONS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)

The blood flow measurement devices market is projected to reach USD 533.0 million by 2021 from USD 343.6 million in 2016, growing at a CAGR of 9.2% in the next five years (2016 to 2021). The growth of the overall blood flow measurement devices market can be contributed to the growing prevalence of cardiovascular diseases and diabetes...

  • Cardiovascular Disease
  • North America
  • United States
  • Compumedics Limited
  • Deltex Medical Group plc
  • Public awareness of cardiovascular diseases
  • Stringent regulatory framework

About Diagnostic Electrodes Electrodes are electrical conductors that can pass energy signals from a power source to a device or a material. Electrodes are made from metals such as zinc, manganese oxide, copper, silver, cadmium, nickel, and others. Electrodes are electrochemical cells that are either called anode or cathode....

  • Cardiac Monitoring
  • Cardiovascular Disease
  • World
  • Forecast
  • Medtronic, Inc.
  • PUBLIC AWARENESS ABOUT CARDIOVASCULAR DISEASES (CVDS)

About Therapeutic Electrodes Electrodes are electrical conductors that are capable of passing energy signals from a power source to a device or a material. Electrodes are made from metals such as zinc, manganese oxide, copper, silver, cadmium, nickel, and others. An electrode is used for the introduction of medicines through...

  • Cardiac Management
  • Cardiovascular Disease
  • World
  • Forecast
  • Medtronic, Inc.
  • GROWING PREVALENCE OF CARDIOVASCULAR DISEASES TO DRIVE MARKET
  • 4.1 HEART PUMP DEVICES MARKET OVERVIEW

The heart pump devices market is projected to grow at a CAGR of 19.4% The global heart pump devices market is projected to reach USD 3.98 billion by 2022 from an estimated USD 1.64 billion in 2017, at a CAGR of 19.4% during the forecast period. Rising prevalence of cardiovascular diseases, increasing number of regulatory...

  • Cardiovascular Disease
  • North America
  • United States
  • Abiomed, Inc.
  • Impella CardioSystems AG
  • Market size and forecast 2017-2022
  • Digital blood pressure monitors market in EMEA 2016-2021 ($ millions)

High blood pressure leading to hypertension is one of primary reason for cardiovascular diseases.

  • Cardiovascular Disease
  • Hospital
  • World
  • Forecast
  • Omron Corporation
  • RISING INCIDENCE OF CARDIOVASCULAR DISEASES (CVDS)
  • SUPPORTIVE GOVERNMENT AND NON-GOVERNMENT INITIATIVES

About Cardiac Rhythm Management (CRM) Devices CRM devices are used for treating all the major heart conditions such as coronary artery disease (CAD), stroke, cardiac arrest, and arrhythmia. The global CRM devices market is increasing owing to the rising prevalence of CVDs, increasing uptake of MCT, and growing patient awareness....

  • Cardiovascular Disease
  • United States
  • Boston Scientific Corporation
  • Jude Medical, Inc.
  • Medtronic, Inc.
  • Women
  • of death By Cause among women in France (number of deaths : 277,141)

Executive Summary A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of Global Biomaterials Market By Type (Metal, Ceramic, Polymer), By Application (Orthopaedic, Cardiovascular,...

  • Cardiovascular Disease
  • North America
  • World
  • Market Size
  • Bayer AG
  • Burden of Cardiovascular Diseases in the U.S. (2017)
  • 2.2 Global TAVI Market Forecast by Value

Transcatheter aortic valve implantation (TAVI) is a relatively new technology in the field of medical science. It is a minimally invasive surgery of replacing heart valve without undergoing the conventional by-pass surgery. It has emerged as one of the most feasible alternatives to conventional surgical aortic valve...

  • Cardiovascular Disease
  • United States
  • Abbott Laboratories, Inc.
  • Boston Scientific Corporation
  • Edwards Lifesciences Corporation
  • MAJOR COMPLICATIONS OF DIABETES
  • Diabetes complications

Cardiovascular diseases are one of the fatal conditions affecting the region.

  • Cardiovascular Disease
  • AstraZeneca PLC
  • Gilead Sciences, Inc.
  • Novartis AG
  • Pfizer Inc.
  • 4.1.3 Rise In The Number of Cardiovascular Procedure and Corresponding Training Programs
  • GLOSSARY OF TERMS

TABLE ##. ##. ## INDIA STRUCTURAL HEART MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) In India, cardiovascular disease have become the major leading cause of the mortality in India which is contributing to the one fourth of the all deaths.

  • Cardiovascular Disease
  • World
  • Forecast
  • Market Size
  • Abbott
  • 5.4.2 CHINA
  • 5.5.1 BRAZIL

In Brazil cardiovascular disease is one among the leading cause of death since 1960s and it is estimated that CVD is responsible for ##% all deaths.

  • Cardiovascular Disease
  • World
  • Market Size
  • Abbott Laboratories, Inc.
  • Boston Scientific Corporation
  • 15.2 BRAZIL CORONARY STENTS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
  • 13.3 CHINA CORONARY STENTS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

Coronary artery disease (CAD) is one of the most common form of cardiovascular disease, which has affected approximately ##. ## million Canadians.

  • Cardiovascular Disease
  • World
  • Forecast
  • Market Size
  • Biosensors International Group, Ltd.

Cost Burden of Cardiovascular Disease, 2015 and 2035 Table ## : Breakdown of U. S.

  • Cardiovascular Disease
  • Diagnostic Imaging
  • World
  • Increasing prevalence of cardiovascular disease (CVD) and government initiatives
  • MARKET DRIVERS

About Coronary Stents Coronary artery disease (CAD) or atherosclerotic heart disease is a type of heart disease that is associated with the hardening of the arteries due to the accumulation of fatty compounds, cholesterol, calcium, and other blood clotting materials in and around the artery wall. These lesions, if become unstable...

  • Cardiovascular Disease
  • United States
  • Abbott Laboratories, Inc.
  • Boston Scientific Corporation
  • Medtronic, Inc.
  • Global heart failure drugs market is expected to grow to $6,804.24 mn by 2022

You can easily book an appointment with one online.

  • Beta-Blocker
  • Cardiovascular Disease
  • Amgen Inc.
  • AstraZeneca PLC
  • Novartis AG
  • MARKET SIZE AND FORECAST 2017-2022
  • EMERGENCE OF TAH

You can easily book an appointment with one online.

  • Cardiovascular Disease
  • Baxter International Inc.
  • Boston Scientific Corporation
  • Fresenius Group
  • Medtronic, Inc.
  • Market drivers
  • Geographical segmentation

About the Cardiology Electrodes Market Cardiology electrodes, composed of metal, lead, plastic, or cloth and electrode conducting gel, help convert ionic energy to electric current in the body and amplify the electric current for the diagnosis and treatment of diseases. These electrodes also help record the heart's electrical activity...

  • Cardiac Monitoring
  • Cardiovascular Disease
  • World
  • CONMED Corporation
  • Medtronic, Inc.